Morgan Stanley Finance LLC has filed a preliminary pricing supplement for a new financial product known as contingent income memory auto-callable securities. This filing, dated October 30, 2026, is significant as it showcases the company's ongoing commitment to expanding its structured investment offerings.
The securities are linked to the performance of the S&P 500 Futures and are designed to provide investors with contingent income based on specific performance metrics. This strategic move indicates Morgan Stanley's effort to tap into the growing demand for structured products that offer unique risk-return profiles.
Background
Morgan Stanley Finance LLC, classified under the SIC code 6211, operates within the Security Brokers, Dealers & Flotation Companies sector. The company is incorporated in Delaware and has its headquarters at 1585 Broadway, New York, NY. Morgan Stanley Finance is a subsidiary of Morgan Stanley, a well-known name in the financial services industry. Recent filings include multiple preliminary pricing supplements and other related documents, all filed on October 30, 2026.
What the Filing Says
The filing includes details about the new securities, stating, "The securities are unsecured obligations of Morgan Stanley Finance LLC and are fully and unconditionally guaranteed by Morgan Stanley." It also highlights that these securities do not guarantee the repayment of principal and do not provide for regular interest payments.
Impact
This new product may attract a range of investors looking for innovative investment opportunities that offer potential above-market returns. The structured nature of the securities means they are designed for investors who are willing to accept higher risks, including the potential loss of principal. As such, this offering could appeal to both retail and institutional investors seeking diversification in their portfolios.
What's Next
The filing does not specify what happens next, but it indicates that the securities will be available for purchase starting from the pricing date of November 30, 2026, with an original issue date set for December 3, 2026. Investors interested in these securities will need to monitor further communications from Morgan Stanley Finance regarding availability and specific terms.
Read Next
BP Sells 5% Stake in Aker BP for $1.06 Billion
WeRide Inc. Reports Stability in Share Capital Movements
Bullish Releases October 2026 Monthly Metrics Report
Chimera Investment Corp declares cash dividends for Q4 2026
Modern Mining Technology registers common shares on NYSE American
Innate Pharma Reports Q3 2026 Update, Highlights Pipeline Progress










